| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |